ABPO

0.900028.77%
LH

Laurie H. Glimcher

Member of Scientific Advisory Board

Dr. Laurie H. Glimcher, M.D., serves as President Emerita of the Dana-Farber Cancer Institute, Inc. since October 2024, where she continues to oversee her lab. At the institute, she also serves as an Attending Physician in the Department of Cancer Immunology and Virology since October 2016, as Director of the Dana-Farber/Harvard Cancer Center, and is a member of the board of trustees. She served as Chief Executive Officer, MD and President of the Dana-Farber Cancer Institute, Inc. from September 2016 to October 2024. She joined the institute in October 2016. Dr. Glimcher serves as the Richard and Susan Smith Professor of Medicine at Harvard Medical School since October 1, 2016 and as a Professor of Microbiology and Immunology since May 2017. She also serves at the Harvard School of Public Health since October 2016. Dr. Glimcher serves as Director at ReAlta Life Sciences, Inc. since April 1, 2025. She is a Director of Bristol-Myers Squibb Farmacutica Portuguesa, SA and a Director of Waters Technologies Corporation since January 1998. She serves as a Non-Executive Director of the Parker Institute for Cancer Immunotherapy and as a Strategic Advisor of J.P. Morgan Life Sciences Private Capital. She is an Associate Rheumatologist at the Brigham and Woman's Hospital. Her advisory roles include serving on the Strategic Advisory Board at Longwood Fund, the Scientific Advisory Board at Abpro Holdings, Inc., the Scientific Advisory Board at Kaleido BioSciences, Inc. since 2019, the Scientific Advisory Council at Cancer Research Institute, Inc., the Blue Ribbon Panel Advisory Board of the National Cancer Institute, and the Blue Ribbon Panel Advisory Board of the American Asthma Foundation. She also serves on the Board of Trustees of Memorial Sloan Kettering Cancer Center and is a member of the Lasker Award Jury. Previously, Dr. Glimcher served as an Independent Director at Analog Devices, Inc. from August 18, 2020 to May 21, 2025, and as an Independent Non-Executive Director of GSK plc from September 1, 2017 to October 13, 2022. She was an Advisor to the Interim Dean and Provost for Medical Affairs and Advisor to the Chairman of the Board of Overseers of Weill Cornell Medical from June 1, 2016. From January 2012 to August 2016, she served as the Stephen and Suzanne Weiss Dean of Weill Cornell Medical College, Professor of Medicine of Weill Cornell Medicine, and the Cornell University Provost for Medical Affairs. She served as an Independent Director at Bristol-Myers Squibb Company from 1997 to July 21, 2017, and as a Trustee of New York Blood Center, Inc. from June 2013 to October 29, 2015. From 1990 to December 2011, she was the Irene Heinz Given Professor of Immunology at the Harvard School of Public Health and Professor of Medicine at Harvard Medical School. She served as an Independent Director at Waters Corporation from January 1998 to August 17, 2020, and as a Director of NDCHealth Corp. from December 18, 2003. Dr. Glimcher also served as Professor of Medicine at Weill Cornell Medical College, Attending Physician at the New York Presbyterian Hospital/Weill Cornell Medical Center, President of the American Association of Immunologists, and on the Scientific Advisory Boards of Immune Disease Institute, Inc., MannKind Corporation, Repare Therapeutics Inc, Abpro Therapeutics, and The Irvington Institute for Immunological Research. Dr. Glimcher is a Member of the National Academy of Sciences, a Fellow of the American Academy of Arts and Sciences, a Member of the American Philosophical Society, a Member of the National Academy of Medicine, and a Fellow of the Royal Society of Biology. She was also elected to the American Society of Clinical Investigation and the American Association of Physicians. She is board Certified in Internal Medicine and Rheumatology. Her awards include the Kober Medal from the American Association of Physicians, the L'Oreal Laureate Award, the Marion Fay Spencer award, the Stohlman Memorial Scholar Award, the FASEB Excellence in Science Award, and the ASCI Outstanding Investigator Award. She holds a B.A., magna cum laude, from Radcliffe College in 1972 and an M.D., cum laude, from Harvard Medical School in 1976.

Positions